MXPA05011464A - Analisis y uso de polimorfismos de par 1 para la estimacion del riesgo de enfermedades cardiovasculares. - Google Patents

Analisis y uso de polimorfismos de par 1 para la estimacion del riesgo de enfermedades cardiovasculares.

Info

Publication number
MXPA05011464A
MXPA05011464A MXPA05011464A MXPA05011464A MXPA05011464A MX PA05011464 A MXPA05011464 A MX PA05011464A MX PA05011464 A MXPA05011464 A MX PA05011464A MX PA05011464 A MXPA05011464 A MX PA05011464A MX PA05011464 A MXPA05011464 A MX PA05011464A
Authority
MX
Mexico
Prior art keywords
par
cardiovascular diseases
polymorphisms
analysis
risk estimation
Prior art date
Application number
MXPA05011464A
Other languages
English (en)
Inventor
Sandrine Mace
Original Assignee
Sanofi Aventis Pharma Deutschl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Pharma Deutschl filed Critical Sanofi Aventis Pharma Deutschl
Publication of MXPA05011464A publication Critical patent/MXPA05011464A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

La invencion se refiere a secuencias de polinucleotidos que comprenden variaciones geneticas del gen PAR 1 en posicion 3090 y/o en posicion 3329. Sorprendentemente, la presencia de dichas variantes en seres humanos se correlaciona con enfermedades cardiovasculares especificas. La invencion se refiere tambien a metodos para la deteccion de dichas variaciones geneticas.
MXPA05011464A 2003-04-24 2004-04-16 Analisis y uso de polimorfismos de par 1 para la estimacion del riesgo de enfermedades cardiovasculares. MXPA05011464A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10318496A DE10318496A1 (de) 2003-04-24 2003-04-24 Analyse und Verwendung von PAR 1 Polymorphismen zur Risikoabschätzung für kardiovaskuläre Erkrankungen
PCT/EP2004/004035 WO2004094470A1 (de) 2003-04-24 2004-04-16 Analyse und verwendung von par 1 polymorphismen zur risikoabschätzung für kardiovaskuläre erkrankungen

Publications (1)

Publication Number Publication Date
MXPA05011464A true MXPA05011464A (es) 2006-03-08

Family

ID=33304897

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011464A MXPA05011464A (es) 2003-04-24 2004-04-16 Analisis y uso de polimorfismos de par 1 para la estimacion del riesgo de enfermedades cardiovasculares.

Country Status (16)

Country Link
EP (1) EP1622940B1 (es)
JP (1) JP4728949B2 (es)
KR (1) KR20060006939A (es)
CN (1) CN1791613A (es)
AT (1) ATE407145T1 (es)
AU (1) AU2004232459B2 (es)
BR (1) BRPI0409688A (es)
CA (1) CA2522815A1 (es)
DE (2) DE10318496A1 (es)
DK (1) DK1622940T3 (es)
ES (1) ES2312990T3 (es)
IL (1) IL171477A (es)
MX (1) MXPA05011464A (es)
NO (1) NO20055538L (es)
RU (1) RU2380422C2 (es)
WO (1) WO2004094470A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453606C2 (ru) * 2010-07-16 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Способ расширенного скрининга предрасположенности к сердечно-сосудистым заболеваниям и биочип для осуществления этого способа

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330790A1 (en) * 1998-05-04 1999-11-11 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Method and device for isolating nucleic acids
DE19819889A1 (de) * 1998-05-04 1999-11-11 Fraunhofer Ges Forschung Verfahren zur Isolierung von Nucleinsäuren
US6322980B1 (en) * 1999-04-30 2001-11-27 Aclara Biosciences, Inc. Single nucleotide detection using degradation of a fluorescent sequence

Also Published As

Publication number Publication date
AU2004232459A1 (en) 2004-11-04
KR20060006939A (ko) 2006-01-20
CA2522815A1 (en) 2004-11-04
WO2004094470A1 (de) 2004-11-04
EP1622940A1 (de) 2006-02-08
DE10318496A1 (de) 2004-11-25
ATE407145T1 (de) 2008-09-15
RU2005136430A (ru) 2006-04-20
NO20055538L (no) 2005-11-23
IL171477A (en) 2010-11-30
BRPI0409688A (pt) 2006-04-18
JP2007534293A (ja) 2007-11-29
DE502004007990D1 (de) 2008-10-16
CN1791613A (zh) 2006-06-21
RU2380422C2 (ru) 2010-01-27
EP1622940B1 (de) 2008-09-03
ES2312990T3 (es) 2009-03-01
DK1622940T3 (da) 2009-01-12
JP4728949B2 (ja) 2011-07-20
AU2004232459B2 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
EP1583770A4 (en) STENOSIS-ASSOCIATED GENETIC POLYMORPHIA, DETECTION METHOD AND ITS USE
PL1730315T3 (pl) Polimorfizmy w genie NOD2/CARD15
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
MX2007012782A (es) Metodos y acidos nucleicos para analisis de trastornos proliferativos celulares.
EP2639317A3 (en) Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
WO2005059108A3 (en) Gene expression profiles and methods of use
EP2249155A3 (en) Cancer markers
EP1948831A4 (en) ALZHEIMER ASSOCIATED GENETIC POLYMORPHISMS, DETECTION METHOD AND USE THEREOF
AU2003259285A8 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
PL1842920T3 (pl) Komórki koekspresjonujące reduktazę witaminy K i białko zależne od witaminy K oraz ich zastosowanie do poprawienia wydajności wytwarzania tego białka zależnego od witaminy K
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2005032495A8 (en) Gene expression profiles and methods of use
PT1673473E (pt) Utilização de polimorfismos genéticos associados à eficácia do tratamento de doenças inflamatórias
WO2004047623A3 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2005014846A3 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2005047536A3 (en) Detection of genomic amplification and deletion in cancer
EP1578951A4 (en) DNA POLYMERASE WITH REDUCED DETECTION ACTIVITY FOR BASE ANALOGS
WO2003035889A3 (en) Compositions and methods for bacteria detection
MXPA05011464A (es) Analisis y uso de polimorfismos de par 1 para la estimacion del riesgo de enfermedades cardiovasculares.
WO2000058510A3 (en) Schizophrenia associated genes, proteins and biallelic markers
WO2006083657A3 (en) Genetic markers associated with benign prostatic hyperplasia
WO2007071437A3 (en) Compositions and methods for treating inflammatory disorders
WO2006006853A3 (en) Differences in intestinal gene expression profiles
WO2006086499A3 (en) Nucleozymes and methods of use

Legal Events

Date Code Title Description
FG Grant or registration